Primary prevention of sudden cardiac death: A rational approach to the use of the implantable cardioverter defibrillator

Journal of Interventional Cardiac Electrophysiology

Volumn 13, Issue 2, 2005, Pages 91-93

  Estes III, N A Mark ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; Implantable cardioverter defibrillator; Sudden death

Indexed keywords

CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS SURGERY; COST BENEFIT ANALYSIS; DEFIBRILLATOR; ECONOMIC ASPECT; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH;

CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PRIMARY PREVENTION;

EID: 23844451793     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-005-0338-6     Document Type: Editorial

References (20)

1. Hlatky MA, Evidence based use of cardiac procedures and devices. N Engl J Med 2004;350:2126-2128.
2. Kadish A, Prophylactic defibrillator implantation-toward an evidence based approach. N Eng J Med 2005;352:285-287.
3. Kadish A, Dyer A, Daubert JP, Quigg R, Estes N, Anderson K, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine J. Defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) Investigtors. N Eng J Med 2004;350;2151-2158.
4. Bristow MR, Saxon L, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White D, DeVriesDW Feldman AM. Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) Investigators, Cardiac-resynchronization therapy with or without an implantable cardioverter defibrillator. N Eng J Med 2004;350:2140-2150.
5. Bardy GH, Lee KL, Mark DB, Poole G, Packer D, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or implantable cardioverter defibrillator for congestive heart failure. N Eng J Med 2005;352:225-237.
6. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488.
7. Cleland JGF, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. For the Cardiac Resynchronization - Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
8. Moss AJ, Hall WJ, Cannom D, Duabert J, Higgins S, Klein H, Levine J, Saksena S, Waldo A, Wilber D, Brown MW, Heo M. Improved survival with an implantable cardioverter defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmias. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Eng J Med 1996;335:1993-1940.
9. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. The Multicenter Automatic Defibrillator Implantation Trial II Investigators. The Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
10. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. For the Multicenter Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890.
11. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445-452.
12. Jauhar S, Slotwiner DJ. The Economics of ICDs. N Eng J Med 2004;351:2542-2544.
13. Pauker S, Estes NAM, Salem D. Preventing Sudden Cardiac Death: Can We Afford the Benefit? Ann Inter Med 2005;142:664-665.
14. Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB. Clinical and economic implications of the Multicenter Automatic Implantable Cardioverter Defibrillator Trail-II. Ann Internal Med 2005;142:593-600.
15. McClelland MB, Tunis, SR. Medicare coverage of ICDs. N Eng J Med 2005;352:222-224.
16. Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R. The cost-effectiveness of automatic implantable cardiac defibrillators: Results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation 1998;97:2129-2135.
17. Mark DB. Cost-effectiveness of ICD therapy in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Presented at the late breaking clinical trials session of the annual meeting of the american heart association, New Orleans, November 10, 2004. Abstract.
18. Bigger JT. Prophylactic use of implanted cardioverter defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Investigators Trial N Eng J Med 1997;337:1569-1575.
19. Curtis AB, Ellenbogen KA, Hammill SC, Hayes D, Reynolds DW, Wilbur DJ, Cain M. Heart Rhythm Society clinical competency statement: Training pathways for implantation of cardioverters and cardiac resynchronization devices. Heart Rhythm 2004:371-3751.
20. Garrett Hardin, The tragedy of the commons. Science 1968;162:1243-1248.